Leronlimab in comparative study published June 18,
Post# of 148110
(Total Views: 592)
Posted On: 06/19/2024 9:18:58 PM
Leronlimab in comparative study published June 18, 2024
Is preexisting inflamed jaw marrow a “hidden” co-morbidity affecting outcomes of COVID-19 infections? – Clinical comparative study
https://pubmed.ncbi.nlm.nih.gov/38889772/
"A possible prophylactic focus for future viral-related pandemics may be early surgical clean-up of CCL5/RANTES expression sources in the FDOJ/AIOJ areas."
This excerpt from their conclusion seems impractical to me.
Is preexisting inflamed jaw marrow a “hidden” co-morbidity affecting outcomes of COVID-19 infections? – Clinical comparative study
https://pubmed.ncbi.nlm.nih.gov/38889772/
"A possible prophylactic focus for future viral-related pandemics may be early surgical clean-up of CCL5/RANTES expression sources in the FDOJ/AIOJ areas."
This excerpt from their conclusion seems impractical to me.
(7)
(0)CytoDyn Inc (CYDY) Stock Research Links
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.
Scroll down for more posts ▼